Safety and Convenience of a 15-Minute Infusion of Zoledronic Acid

Safety and Convenience of a 15-Minute Infusion of Zoledronic Acid James Berenson, Raimund Hirschberg Oncologist 2004; 9: 319-329 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in symptom management and supportive care and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Describe the effects of bisphosphonates on bone metabolism in patients with metastatic bone disease. Explain the ability of intravenous bisphosphonates to reduce skeletal complications in patients with metastatic bone disease. Identify differences among the different bisphosphonates in their efficacies at reversing hypercalcemia of malignancy. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: May 28, 2004 Most Recent Review: May 28, 2004* Most Recent Update: May 28, 2004 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.